What are the key considerations for selecting a point of care (POC) machine for measuring Hemoglobin A1c (HbA1c) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

When selecting a Point of Care (POC) machine for hemoglobin A1c testing, I recommend focusing on devices with NGSP certification (National Glycohemoglobin Standardization Program) and FDA clearance, as emphasized in the most recent guidelines 1. The key considerations for selecting a POC machine include:

  • NGSP certification to ensure accurate and reliable results
  • FDA clearance for safety and efficacy
  • Test time, with most devices ranging from 5-15 minutes
  • Sample volume requirements, typically 1-5 μL of capillary blood
  • Cost per test, generally $7-15
  • Connectivity features for electronic medical record integration
  • Maintenance requirements and calibration frequency, which vary between models
  • Staff training needs and physical space requirements It is essential to consider these factors to ensure accurate diabetes management and improve patient outcomes. The clinical value of POC A1c testing lies in its ability to provide immediate results during patient visits, allowing for real-time treatment adjustments and potentially improving diabetes outcomes through immediate feedback and enhanced patient engagement, as supported by recent guidelines 1. When interpreting A1C results, it is crucial to consider factors that may affect hemoglobin or red blood cells, such as conditions that affect red blood cell turnover, hemoglobin variants, and certain medical conditions, as highlighted in the recent study 1. In individuals with conditions that interfere with the interpretation of A1C, alternative approaches to monitoring glycemic status should be used, including self-monitoring of blood glucose, CGM, and/or the use of glycated serum protein assays, as recommended in the recent guidelines 1.

From the Research

Key Considerations for Selecting a Point of Care (POC) Machine

When selecting a POC machine for measuring Hemoglobin A1c (HbA1c) levels, several key considerations must be taken into account. These include:

  • Accuracy: The POC machine should provide accurate results, with a high correlation coefficient compared to a reference method 2, 3, 4, 5.
  • Precision: The machine should have a low coefficient of variation (CV) to ensure reliable results 3, 4.
  • Ease of use: The machine should be easy to operate, with a user-friendly interface 6.
  • Cost: The cost of the machine, as well as the cost of consumables and maintenance, should be considered 6.
  • Additional features: Some machines may offer additional features, such as the ability to test for other parameters or to connect to electronic health records 6.

Performance Criteria

The National Glycohemoglobin Standardization Program (NGSP) has established performance criteria for POC HbA1c machines, including:

  • Accuracy: The machine should have a correlation coefficient of at least 0.98 compared to a reference method 2, 4.
  • Precision: The machine should have a CV of less than 3% 3, 4.
  • Bias: The machine should have a bias of less than ±0.5% compared to a reference method 2, 4.

Comparison of POC Machines

Several studies have compared the performance of different POC HbA1c machines, including:

  • A1CNow + 2
  • Afinion AS100 4, 5
  • DCA Vantage 4, 5
  • In2it 4
  • A1C EZ 2.0 3 These studies have shown that some machines, such as the Afinion AS100, meet the NGSP performance criteria, while others, such as the In2it, do not 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation of a new hemoglobin A1c analyzer for point-of-care testing.

Journal of clinical laboratory analysis, 2018

Research

Accuracy of three hemoglobin A1c point-of-care systems for glucose monitoring in patients with diabetes mellitus.

Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2015

Research

Selecting an A1C Point-of-Care Instrument.

Diabetes spectrum : a publication of the American Diabetes Association, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.